AHI1 Antibodies

Santa Cruz Biotechnology offers a broad range of AHI1 monoclonal antibodies for investigating AHI1 in various biological processes. AHI1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AHI1, or Absent in Human 1, is a protein that plays a crucial role in neuronal development and function. Research has shown AHI1's involvement in several neurodevelopmental disorders, making it a significant focus in neurobiology studies. Understanding AHI1 function can provide insights into the molecular mechanisms underlying various conditions. Ongoing research continues to reveal new aspects of AHI1's involvement in cellular processes and disease pathways. Current studies are exploring AHI1's potential as a therapeutic target in neurological disorders. Investigating AHI1 expression patterns helps researchers better understand its role in brain development and neural circuit formation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance neuroscience research and contribute to potential therapeutic breakthroughs.